T37.1X5 Category · further specificity required Adverse effect of antimycobacterial drugs
ICD-10-CM T37.1X5 identifies “Adverse effect of antimycobacterial drugs” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 19: Injury, poisoning and certain other consequences of external causes
Code-level instructions
No additional notes.
Inherited instructions
Chapters 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T37 · Poisoning by, adverse effect of and underdosing of other systemic anti-infectives and antiparasitics
Excludes 13
Seventh character1
The appropriate 7th character is to be added to each code from category T37
A — initial encounter
D — subsequent encounter
S — sequela
T37.1 · Poisoning by, adverse effect of and underdosing of antimycobacterial drugs
More specific codes
Official index references
Official index references (71)
Acetosulfone(sodium) (1)
- Acetosulfone(sodium)Drugs and chemicals
Aldesulfone sodium (1)
- Aldesulfone sodiumDrugs and chemicals
Aminosalicylic acid (1)
- Aminosalicylic acidDrugs and chemicals
Aminosalylum (1)
- AminosalylumDrugs and chemicals
Anti-infective NEC (1)
- Anti-infective NEC › antimycobacterial NECDrugs and chemicals
Antimycobacterial drug NEC (2)
- Antimycobacterial drug NECDrugs and chemicals
- Antimycobacterial drug NEC › combinationDrugs and chemicals
Antituberculars (1)
- AntitubercularsDrugs and chemicals
Avlosulfon (1)
- AvlosulfonDrugs and chemicals
Benzamidosalicylate(calcium) (1)
- Benzamidosalicylate(calcium)Drugs and chemicals
Benzoylpas calcium (1)
- Benzoylpas calciumDrugs and chemicals
Bromosalicylhydroxamic acid (1)
- Bromosalicylhydroxamic acidDrugs and chemicals
Calcium (1)
- Calcium › benzamidosalicylateDrugs and chemicals
Chaulmosulfone (1)
- ChaulmosulfoneDrugs and chemicals
Clofazimine (1)
- ClofazimineDrugs and chemicals
Cyanacetyl hydrazide (1)
- Cyanacetyl hydrazideDrugs and chemicals
Cycloserine (1)
- CycloserineDrugs and chemicals
DADPS (1)
- DADPSDrugs and chemicals
Dapsone (1)
- DapsoneDrugs and chemicals
DDS (1)
- DDSDrugs and chemicals
Diaminodiphenylsulfone (1)
- DiaminodiphenylsulfoneDrugs and chemicals
Diasone(sodium) (1)
- Diasone(sodium)Drugs and chemicals
Etambutol (1)
- EtambutolDrugs and chemicals
Ethambutol (1)
- EthambutolDrugs and chemicals
Ethionamide (1)
- EthionamideDrugs and chemicals
Ethioniamide (1)
- EthioniamideDrugs and chemicals
Ethyl (1)
- Ethyl › chaulmoograteDrugs and chemicals
Fenamisal (1)
- FenamisalDrugs and chemicals
Glucosulfone sodium (1)
- Glucosulfone sodiumDrugs and chemicals
Glyconiazide (1)
- GlyconiazideDrugs and chemicals
INH (1)
- INHDrugs and chemicals
Isoniazid (2)
- IsoniazidDrugs and chemicals
- Isoniazid › with › thioacetazoneDrugs and chemicals
Isonicotinic acid hydrazide (1)
- Isonicotinic acid hydrazideDrugs and chemicals
Izoniazid (2)
- IzoniazidDrugs and chemicals
- Izoniazid › with thioacetazoneDrugs and chemicals
Methaniazide (1)
- MethaniazideDrugs and chemicals
Morinamide (1)
- MorinamideDrugs and chemicals
Morphazinamide (1)
- MorphazinamideDrugs and chemicals
Nydrazid (1)
- NydrazidDrugs and chemicals
Para-aminosalicylic acid (1)
- Para-aminosalicylic acidDrugs and chemicals
PAS (1)
- PASDrugs and chemicals
Pasiniazid (1)
- PasiniazidDrugs and chemicals
Pentylsalicylamide (1)
- PentylsalicylamideDrugs and chemicals
Pirazinamide (1)
- PirazinamideDrugs and chemicals
Potassium(salts) NEC (1)
- Potassium(salts) NEC › aminosalicylateDrugs and chemicals
Promacetin (1)
- PromacetinDrugs and chemicals
Promin (1)
- ProminDrugs and chemicals
Prothionamide (1)
- ProthionamideDrugs and chemicals
Protionamide (1)
- ProtionamideDrugs and chemicals
Pyrazinamide (1)
- PyrazinamideDrugs and chemicals
Pyrazinoic acid(amide) (1)
- Pyrazinoic acid(amide)Drugs and chemicals
Rifampicin (1)
- Rifampicin › with isoniazidDrugs and chemicals
Rimifon (1)
- RimifonDrugs and chemicals
Salinazid (1)
- SalinazidDrugs and chemicals
Sodium (3)
- Sodium › acetosulfoneDrugs and chemicals
- Sodium › glucosulfoneDrugs and chemicals
- Sodium › sulfoxoneDrugs and chemicals
Solapsone (1)
- SolapsoneDrugs and chemicals
Solasulfone (1)
- SolasulfoneDrugs and chemicals
Sulfonazide (1)
- SulfonazideDrugs and chemicals
Sulfones (1)
- SulfonesDrugs and chemicals
Sulfoxone (1)
- SulfoxoneDrugs and chemicals
Sulphadione (1)
- SulphadioneDrugs and chemicals
Terizidone (1)
- TerizidoneDrugs and chemicals
Thiambutosine (1)
- ThiambutosineDrugs and chemicals
Thioacetazone (2)
- ThioacetazoneDrugs and chemicals
- Thioacetazone › with isoniazidDrugs and chemicals
Thiocarlide (1)
- ThiocarlideDrugs and chemicals
Tiocarlide (1)
- TiocarlideDrugs and chemicals
Trecator (1)
- TrecatorDrugs and chemicals
History
Code history
Latest recorded change · FY2025 · 04-01
Effective from
- Inherited rules changed
Adverse effect of antimycobacterial drugs
Category — select a more specific code
CDC/NCHS · FY2025 · 04-01All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | Inherited rules changed |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | Inherited rules changed |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | Inherited rules changed |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.